Maca Root Extract

Maca root extract is a powdered or concentrated preparation from the hypocotyl of Lepidium meyenii, a cruciferous vegetable native to the Peruvian Andes. It has been cultivated and consumed as a food and traditional tonic for over 2000 years. In modern food supplements, maca is positioned for energy, vitality, libido, and reproductive health support, primarily in adult demographics.

For private-label brands, maca offers a well-recognised botanical with strong consumer awareness in the EU, UK, and US markets. Its earthy, slightly sweet flavour profile works well in gummy formats, though the high effective dose — typically 1500 mg to 3500 mg per serving — means it is better suited to multi-gummy servings or sachet formats. Maca has no EFSA-authorised health claims, so brands must position it on traditional use or co-formulate with nutrients that carry authorised claims.

Origin and history

Maca has been cultivated in the high-altitude regions of Peru, particularly around Lake Junin, for at least two millennia. It was traditionally used by indigenous Andean populations as a food source and for its perceived effects on fertility, energy, and stamina. Spanish colonial records from the 16th century document its use as a staple crop and trade good.

Industrial production of maca extract began in the late 20th century as global interest in adaptogenic and traditional botanicals grew. Today, maca is primarily cultivated in Peru, with the dried hypocotyls processed into powder or concentrated extracts. Gelatinised maca — where the starch is pre-cooked to improve digestibility — is the most common form used in supplements. The ingredient is now widely available through established supply chains serving the EU, UK, and US markets.

Scientific overview

Maca contains a range of bioactive compounds including macamides, macaenes, glucosinolates, and alkaloids. Macamides, a class of fatty acid amides unique to maca, are considered the primary bioactive markers and are often used for standardisation. Research suggests maca may influence the hypothalamic-pituitary-gonadal axis, though the exact mechanisms are not fully characterised. Most published studies use doses between 1500 mg and 3500 mg per day.

Bioavailability of maca compounds is not well studied in humans. The gelatinised form is thought to improve digestibility and nutrient release compared to raw powder. Standardised extracts (e.g., 4:1 or 10:1 concentration) allow for smaller serving sizes, which is advantageous for gummy formats. However, even concentrated extracts require careful formulation to achieve effective doses within a reasonable number of gummies.

From a manufacturing perspective, maca is heat-stable and soluble in gummy matrices, which simplifies processing. The earthy flavour can be masked with complementary fruit or chocolate profiles. The primary manufacturing challenge is the payload: a 2000 mg dose of maca powder requires at least four standard 500 mg gummies. Concentrated extracts reduce this but increase cost per serving. DAT reviews formulation options per project.

Maca is one of the most familiar and commercially understood botanical actives across EU and US markets. Its positioning spans energy, vitality, libido, and reproductive health — categories with strong consumer demand. Brands targeting active adults, men over 40, or women seeking hormonal support frequently include maca in their product ranges. The ingredient's traditional use story and Peruvian origin add authenticity and differentiation on shelf.

From a formulation standpoint, maca's heat stability and solubility make it technically feasible in gummies. The earthy flavour is manageable with careful flavouring. The main tradeoff is dose density: brands must decide between a high-count serving (4–6 gummies) or using a concentrated extract at higher cost. Sachet formats offer an alternative route for higher doses with simpler formulation. DAT reviews the optimal format and dose per project.

For pack copy, brands must observe strict claim discipline. Maca has no EFSA-authorised health claims under Reg. 432/2012. Consumer-facing claims should be limited to traditional use descriptions or food supplement status. If co-formulated with nutrients such as Zinc or Vitamin B6, those nutrients' authorised claims can be used on pack. DAT reviews all pack copy per project before production to ensure compliance.